Found 5 results

Name Type of Offering Accepted Date
AgeX Therapeutics, Inc. See All Filings
D 2018-01-31 17:26:04
Amount To Be Raised $1,000,000
Associated Brokers / Dealers N/A
CIK Number 0001708599
Filed Document 0001462573-18-000001
Exclusions or Exemptions 506b
Accepted Date 2018-01-31 17:26:04
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
AgeX Therapeutics, Inc. See All Filings
D 2018-06-21 12:21:37
Amount To Be Raised $5,000,000
Associated Brokers / Dealers N/A
CIK Number 0001708599
Filed Document 0001462573-18-000002
Exclusions or Exemptions 506b
Accepted Date 2018-06-21 12:21:37
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
AgeX Therapeutics, Inc. See All Filings
D 2018-08-27 11:45:04
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001708599
Filed Document 0001462573-18-000003
Exclusions or Exemptions 506b
Accepted Date 2018-08-27 11:45:04
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
AgeX Therapeutics, Inc. See All Filings
D 2017-07-10 17:11:42
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001708599
Filed Document 0001462573-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-07-10 17:11:42
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity
AgeX Therapeutics, Inc. See All Filings
D 2019-03-22 16:19:34
Amount To Be Raised $5,000,000
Associated Brokers / Dealers N/A
CIK Number 0001708599
Filed Document 0001462573-19-000001
Exclusions or Exemptions 506b
Accepted Date 2019-03-22 16:19:34
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business CALIFORNIA
Revenue or Assets Decline to Disclose
Type of Security Equity